What Does the Evidence Say About Supplements for Achilles Recovery?

Adequate total protein intake is the single most important nutritional intervention during Achilles rupture recovery — and the most commonly neglected. Muscle atrophy during immobilisation is substantial and occurs rapidly. Without sufficient dietary protein, the body cannot maintain lean mass even with active rehabilitation.

The immobilised limb undergoes anabolic resistance — meaning muscle protein synthesis is blunted in response to both feeding and exercise. Higher protein intakes (towards 2.2g/kg/day) help counteract this resistance. Protein should be distributed across 4–5 meals per day rather than concentrated in one or two large servings, as muscle protein synthesis responds to the per-meal protein stimulus rather than total daily intake alone.

The most commonly discussed supplement in tendon recovery — and the one with the most specific evidence. The Shaw et al. 2017 RCT found that consuming 15g of gelatin (a food-derived form of hydrolysed collagen) enriched with approximately 50mg of Vitamin C, one hour before a short loading exercise bout, doubled markers of collagen synthesis (N-terminal peptide of procollagen I, PINP) compared to placebo. The effect was dose-dependent — 5g produced significantly less effect than 15g. Engineered ligaments treated with media from supplemented subjects showed increased collagen content and improved mechanics.

A 2021 systematic review (PMC8521576) confirmed that collagen supplementation combined with loading exercise increases circulating collagen synthesis markers. The proposed mechanism is that exercise creates a mechanical signal in tendon tissue (mechano-transduction), and the simultaneous elevation of collagen-specific amino acids in circulation provides the building blocks for the tendon to act on that signal.

Vitamin C is a mandatory co-factor for the enzymes prolyl hydroxylase and lysyl hydroxylase — which hydroxylate proline and lysine residues in procollagen. Without adequate Vitamin C, procollagen cannot be hydroxylated into the stable triple helix structure required for mature collagen. Deficiency impairs collagen synthesis regardless of other nutritional interventions.

The mechanistic evidence for Vitamin C's role in collagen synthesis is well established and has been confirmed in multiple studies. A 2024 RCT on Vitamin C injection (rather than oral supplementation) for flexor tendon healing found positive effects on collagen production and tendon repair, further supporting the mechanistic importance of Vitamin C in tendon healing contexts.

Creatine monohydrate is the most extensively researched ergogenic supplement in sports science. Its relevance to Achilles recovery lies specifically in its ability to support muscle strength recovery during rehabilitation — not in any direct effect on tendon tissue itself.

The evidence picture is more nuanced than most supplement guides present. Older RCTs found creatine supplementation combined with rehabilitation training accelerated strength recovery and upregulated myogenic transcription factors (MyoD, myogenin) after immobilisation and rehabilitation. However, a 2017 RCT by Backx et al. (PMC5507980) specifically found that creatine loading did NOT prevent muscle mass or strength loss during 7 days of single-leg immobilisation — concluding that creatine should be removed "from the list of potential nutritional compounds that may help prevent disuse atrophy." The authors note creatine may still be useful during active rehabilitation to enhance the adaptive response to resistance exercise.

The current evidence therefore suggests: creatine is most beneficial when combined with active resistance rehabilitation (physiotherapy, progressive loading), rather than during the pure immobilisation phase. When combined with structured loading, a meta-analysis of strength outcomes (PMC12665265, 14 studies, 523 participants) found a significant advantage favouring creatine supplementation (SMD 0.43, 95% CI 0.25–0.61, P<0.01).

Omega-3 fatty acids (specifically EPA and DHA from fish oil) have anti-inflammatory properties and emerging evidence for attenuating muscle atrophy during immobilisation. The landmark human RCT (McGlory et al. 2019, FASEB J) found that omega-3 supplementation (5g/day beginning 4 weeks before immobilisation) attenuated the decline in muscle volume during 2 weeks of unilateral leg immobilisation in young women — the control group lost 14% of muscle volume compared to 8% in the omega-3 group. Muscle protein synthesis (MyoPS) was also higher in the omega-3 group throughout immobilisation and recovery.

A PubMed review (Phillips SM 2021) concluded omega-3 fatty acid supplementation is "a potential preventive therapy to combat skeletal muscle-disuse atrophy" while noting that "additional, appropriately powered randomised controlled trials are now needed in a range of populations before firm conclusions can be made." The Gatorade Sports Science Institute review also noted a "prehabilitative/rehabilitative role" for omega-3 during injury-induced muscle disuse.

The evidence is primarily from studies in women and from limb immobilisation contexts rather than Achilles rupture specifically. The safety profile of fish oil at these doses is well established, and the plausible mechanism (enhanced muscle protein synthesis, reduced proteolysis) is supported by multiple lines of evidence. The cost and risk are low relative to the potential benefit.

PRP is included here because it is frequently discussed alongside supplements in the context of Achilles recovery — and because the gap between its marketing and its evidence base is among the largest in this field. PRP is not an oral supplement but an autologous injection of concentrated platelets, and its inclusion reflects the volume of patient enquiry it generates.

The PATH-2 trial — a multicentre, participant and assessor-blinded RCT of 230 patients across 19 UK hospitals — found no difference between PRP injection and placebo (dry needle in the rupture gap) on any outcome measure at 24 weeks, including Limb Symmetry Index, ATRS, pain, or quality of life. The 2-year follow-up of the same trial (Keene et al. Bone Joint J 2022) confirmed: "The evidence from this study indicates that PRP offers no patient benefit in the longer term for patients with acute Achilles tendon rupture."

A systematic review and meta-analysis of 6 studies with 510 patients (Boksh et al. The Foot 2022) found no improvement in biomechanical outcomes, patient-reported outcomes, or re-rupture rates (OR 1.13, 95% CI 0.46–2.80, P=0.79) with PRP injection. A separate meta-analysis for Achilles tendinopathy (not rupture) covering 6 RCTs and 422 patients found no benefit on VISA-A scores at 3, 6, or 12 months.

Glucosamine and chondroitin are primarily studied for articular cartilage — not tendon tissue. Cartilage and tendon have fundamentally different compositions, cell types, and metabolic needs. Evidence for glucosamine in osteoarthritis is mixed even for its intended indication. There is no meaningful clinical evidence for glucosamine or chondroitin supplementation in Achilles tendon rupture recovery. Not recommended.

Curcumin (the active compound in turmeric) has plausible anti-inflammatory and antioxidant mechanisms that are theoretically relevant to soft tissue recovery. In vitro and animal studies are promising. However, human RCT evidence for curcumin in Achilles tendon rupture or tendon healing specifically does not currently exist at a meaningful scale. Bioavailability of curcumin from standard turmeric powder is poor — piperine or liposomal delivery systems substantially improve absorption. The evidence does not currently support a recommendation, but the risk profile is low.

Magnesium plays a role in hundreds of enzymatic reactions including muscle protein synthesis and ATP production. Deficiency impairs muscle function. However, for individuals with adequate dietary magnesium intake (achievable through leafy greens, nuts, seeds, and whole grains), supplementation provides no additional benefit. There is no evidence for magnesium supplementation specifically improving Achilles tendon healing. If you are deficient — which blood testing can confirm — correction is warranted. If you are not deficient, supplementation is unlikely to benefit recovery.

Standard collagen tablets (as opposed to hydrolysed collagen peptides) have a different molecular weight profile that may result in lower bioavailability of the specific amino acids relevant to tendon collagen synthesis. The Shaw et al. 2017 protocol used hydrolysed gelatin — a form whose amino acids are pre-processed for absorption. Standard collagen tablets are typically lower dose and lack the evidence base of hydrolysed peptide products. If you are using collagen for tendon recovery, hydrolysed peptide powder (taken per the protocol above) is the evidence-supported form.